OnabotulinumtoxinA Injections for the Treatment of Myofascial Pelvic Pain: 12-year Experience at a Tertiary Care Academic Center
CONCLUSION: OnabotulinumtoxinA is beneficial in treating women with MFPP; with a duration of therapeutic effect of approximately 6 months. The use of a concurrent pudendal nerve block did not impact clinical outcomes.
Source: Gynecologic and Obstetric Investigation - Category: OBGYN Source Type: research
More News: Academia | Constipation | Emergency Medicine | Incontinence | OBGYN | Pain | Statistics | Study | Urinary Tract Infections | Women